Midazolam hydrochloride is the hydrochloride salt of midazolam. It has a role as an anticonvulsant, an antineoplastic agent, an anxiolytic drug, an apoptosis inducer, a central nervous system depressant, a GABAA receptor agonist, a general anaesthetic, a muscle relaxant and a sedative. It is an imidazobenzodiazepine and a hydrochloride. It contains a midazolam.
This report contains market size and forecasts of Midazolam Hydrochloride in global, including the following market information:
Global Midazolam Hydrochloride Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Midazolam Hydrochloride Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Midazolam Hydrochloride companies in 2021 (%)
The global Midazolam Hydrochloride market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Midazolam Hydrochloride Syrup Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Midazolam Hydrochloride include Hikma Pharmaceuticals, Pfizer, Fresenius Kabi, Akorn Pharmaceuticals, Gland Pharma, PADAGIS, Meridian Medical Technologies, Alvogen and Precision Dose, Inc.. etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Midazolam Hydrochloride manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Midazolam Hydrochloride Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Midazolam Hydrochloride Market Segment Percentages, by Type, 2021 (%)
Midazolam Hydrochloride Syrup
Midazolam Hydrochloride Injection
Global Midazolam Hydrochloride Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Midazolam Hydrochloride Market Segment Percentages, by Application, 2021 (%)
Hospitals & Clinics
Pharmacy Retail
Others
Global Midazolam Hydrochloride Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Midazolam Hydrochloride Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Midazolam Hydrochloride revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Midazolam Hydrochloride revenues share in global market, 2021 (%)
Key companies Midazolam Hydrochloride sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Midazolam Hydrochloride sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Hikma Pharmaceuticals
Pfizer
Fresenius Kabi
Akorn Pharmaceuticals
Gland Pharma
PADAGIS
Meridian Medical Technologies
Alvogen
Precision Dose, Inc.